Aquestive Therapeutics sees FY24 revenue $57M-$60M, consensus $58.01M
The Fly

Aquestive Therapeutics sees FY24 revenue $57M-$60M, consensus $58.01M

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App